BSE filing, BSE: 544091. Summary written from the filing by ALFA Finder's alert engine.
Qualitek Labs Ltd: key numbers
- Share price
- ₹502.00
- Market cap
- ₹501.0 Cr
- Revenue (annual)
- ₹124.5 Cr
- Net profit (annual)
- ₹13.62 Cr
- P/E (TTM)
- 36.8×Sector 45.1×
- Promoter holding
- 56.46%
- FII holding
- 1.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Qualitek Labs Ltd
All →Qualitek Labs Management Change
Qualitek Labs' Independent Director Ajay Agarwal resigned effective October 29, 2026, citing personal reasons. He was not on any board committee, so no reconstitution is required.
Qualitek Labs Bags New Order from Bio-Resources Development Centre, Government of Meghalaya
Qualitek Labs' subsidiary Interstellar Testing Centre received a work order from BRDC, Government of Meghalaya for laboratory setup and accreditation. Value is undisclosed citing commercial confidentiality.
- From
- Bio-Resources Development Centre (BRDC), Government of Meghalaya
Qualitek Labs Annual General Meeting
Qualitek Labs issued a corrigendum to its EGM notice scheduled for October 16, 2026. The amendment clarifies shareholding pattern disclosures related to the proposed preferential allotment.
Qualitek Labs Other Announcement
Qualitek Labs Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations for the period ended September 30, 2026.
Qualitek Labs Annual General Meeting
Qualitek Labs Limited held its 8th Annual General Meeting on September 25, 2026. Shareholders approved financial statements, re-appointment of the MD, and material related party transactions.
Qualitek Labs Annual General Meeting
Qualitek Labs Ltd issued an EGM notice to seek shareholder approval for a preferential issuance of 3.86 lakh equity shares and 5.20 lakh convertible warrants.
- Value
- ₹46.98 Cr
Other board meeting date announcements
All →Veto Switchgears & Cables Board Meeting Date
Veto Switchgears and Cables will hold a board meeting on 6 November 2026 to consider unaudited standalone and consolidated quarterly results to September 2026. The trading window stays closed from 1 October to 8 November 2026.
Arihant Foundations & Housing Board Meeting Date
Arihant Foundations & Housing has scheduled a board meeting for 6 November 2026 to consider a second tranche of unlisted NCDs. No amount is stated.
Medico Remedies Board Meeting Date
Medico Remedies gave advance notice of a 9 November 2026 board meeting to consider unaudited standalone results for the quarter ended September 2026. The trading window is closed from 1 October to 12 November 2026.
NHC Foods Board Meeting Date
NHC Foods will hold a board meeting on 07-Nov-2026 to consider unaudited standalone and consolidated results for the half year ended September 2026. The trading window stays closed until 48 hours after the outcome.
Pashupati Cotspin Board Meeting Date
Pashupati Cotspin will hold a board meeting on 06-Nov-2026 to consider unaudited quarterly and half-year results for September 2026 and a possible interim dividend. The trading window closes from 01-Oct-2026.
Shreeoswal Seeds and Chemicals Board Meeting Date
ShreeOswal Seeds And Chemicals will hold a board meeting on 14-Nov-2026 to consider unaudited half-yearly standalone and consolidated results for September 2026. Trading window closes from 01-Oct-2026 until 16-Nov-2026.